These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11797299)

  • 21. Prostate brachytherapy: treatment strategies.
    Stone NN; Stock RG
    J Urol; 1999 Aug; 162(2):421-6. PubMed ID: 10411050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Standards, Options and Recommendations (SOR) for tumor markers in breast cancer. SOR Working Group].
    Basuyau JP; Blanc-Vincent MP; Bidart JM; Daver A; Deneux L; Eche N; Gory-Delabaere G; Pichon MF; Riedinger JM
    Bull Cancer; 2000 Oct; 87(10):723-37. PubMed ID: 11084536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Standards, options and recommendations (SOR) for clinical care of malignant thymoma. Groupe de Travail SOR].
    Ruffié P; Gory-Delabaere G; Fervers B; Lehmann M; Regnard JF; Resbeut M
    Bull Cancer; 1999 Apr; 86(4):365-84. PubMed ID: 10341342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer.
    Crook J; Lukka H; Klotz L; Bestic N; Johnston M;
    CMAJ; 2001 Apr; 164(7):975-81. PubMed ID: 11314451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controversies in prostate cancer radiotherapy: consensus development.
    Lukka H; Warde P; Pickles T; Morton G; Brundage M; Souhami L;
    Can J Urol; 2001 Aug; 8(4):1314-22. PubMed ID: 11564274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Standards, Options, and Recommendations for the management of patients with malignant mesothelioma of the pleura. Fédération Nationale des Centres de Lutte Contre le Cancer].
    Ruffié P; Lehmann M; Galateau-Sallé F; Lagrange JL; Pairon JC
    Bull Cancer; 1998 Jun; 85(6):545-61. PubMed ID: 9752282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Standards, Options and Recommendations for the management of invasive cervical cancer patients (non metastastic)].
    Resbeut M; Fondrinier E; Fervers B; Haie-Meder C; Bataillard A; Lhommé C; Asselain B; Basuyau JP; Brémond A; Castaigne D; Dubois JB; Houvenaeghel G; Lartigau E; Leblanc E; Sastre-Garau X; Sarradet A; Guastalla JP; Chauvergne J; ; ; ; ; ;
    Bull Cancer; 2003 Apr; 90(4):333-46. PubMed ID: 12801817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical practice guidelines: Standards, Options and Recommendations for first line medical treatment of patients with ovarian neoplasms (summary report)].
    Lhommé C; Ray-Coquard I; Guastalla JP; Bataillard A; Thomas L; Bonnier P; Dargent D; Dohollou N; Ganem G; Lefranc JP; Misset JL; Rixe O; Tchiknavorian X; Tournigand C; Villet R; Bachelot T; Kerbrat P; Fervers B; Basuyau JP; Cohen-Solal-Le Nir C; Morice P; Duvillard P; Voog E; ; ; ; ; ;
    Bull Cancer; 2004; 91(7-8):609-20. PubMed ID: 15381451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Standards and Options for the use of radiation therapy in the management of patients with osteosarcoma. Update 2004].
    Claude L; Rousmans S; Carrie C; Breteau N; Dijoud F; Gentet JC; Giammarile F; Jouve JL; Kind M; Marec-Bérard P; Mascard E; Bataillard A; Philip T; ; ; ; ; ; ; ;
    Bull Cancer; 2005 Oct; 92(10):891-906. PubMed ID: 16266873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Standards, Options, and Recommendations for the management of brief neutropenias. Fedération Nationale des Centres de Lutte Contre le Cancer].
    Biron P; Fuhrmann C; Escande MC; Blanc-Vincent MP; Crokaert F; Béal J; Bussy V; Lesimple T; Pottecher B; Raveneau J; Senet JM; Viot M
    Bull Cancer; 1998 Aug; 85(8):695-711. PubMed ID: 9754078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical practice guidelines: 2004 Standards, Options and Recommendations for the management of patient with adenocarcinoma of the stomach--radiotherapy].
    Ychou M; Gory-Delabaere G; Blanc P; Bosquet L; Duffour J; Giovannini M; Guillemin F; Lemanski C; Marchal F; Masson B; Merrouche Y; Monges G; Adenis A; Bosset JF; Bouché O; Conroy T; Pezet D; Triboulet JP; ; ;
    Cancer Radiother; 2004 Oct; 8(5):322-35. PubMed ID: 15561598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Standards, options and recommendations: nutritional support in palliative or terminal care of adult patients with progressive cancer].
    Bachmann P; Marti-Massoud C; Blanc-Vincent MP; Desport JC; Colomb V; Dieu L; Kere D; Melchior JC; Nitenberg G; Raynard B; Roux-Bournay P; Schneider S; Senesse P
    Bull Cancer; 2001 Oct; 88(10):985-1006. PubMed ID: 11713035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Standards, options and recommendations (SOR) for clinical care of squamous cell carcinoma of the oropharynx. Groupe de travail SOR].
    Renaud-Salis JL; Blanc-Vincent MP; Brugère J; Demard F; Faucher A; Gory-Delabaere G; Pinsolle J
    Bull Cancer; 1999 Jun; 86(6):550-72. PubMed ID: 10417429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Permanent prostate brachytherapy and short-term androgen deprivation for intermediate-risk prostate cancer in Japanese men: outcome and toxicity.
    Yamada Y; Masui K; Iwata T; Naitoh Y; Yamada K; Miki T; Okihara K
    Brachytherapy; 2015; 14(2):118-23. PubMed ID: 25304650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology. Fédération Nationale des Centres de Lutte Contre le Cancer].
    Pottecher B; Herbrecht R; Blanc-Vincent MP; Bussy Malgrange V; Escande MC; Fuhrmann C; Crokaert F; Gory-Delabaere G; Senet JM; Lesimple T; Raveneau J; Béal J; Biron P; Viot M
    Bull Cancer; 2000 Jul; 87(7-8):557-91. PubMed ID: 10969214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Standards, Options and Recommendations (SOR) for the use of appetite stimulants in oncology. Work group. Federation of the French Cancer Centres (FNCLCC)].
    Desport JC; Blanc-Vincent MP; Gory-Delabaere G; Bachmann P; Béal J; Benamouzig R; Colomb V; Kere D; Melchior JC; Nitenberg G; Raynard B; Scheiner S; Senesse P
    Bull Cancer; 2000 Apr; 87(4):315-28. PubMed ID: 10827350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [2003 update of Standards, Options and Recommandations for radiotherapy for patients with salivary gland malignant tumors (excluding lymphona, sarcoma and melanoma)].
    Bensadoun RJ; Allavena C; Chauvel P; Dassonville O; Demard F; Dieu-Bosquet L; Lacau St Guily J; Ettore F; Gory-Delabaere G; Marcy PY; Reyt E; ; ; ; ; ;
    Cancer Radiother; 2003 Aug; 7(4):280-95. PubMed ID: 12914861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.